-
-
-
-
-
-
-
BioMarin to Host First Quarter 2026 Financial Results Conference Call and Webcast on Monday, May 4, 2026, at 4:30pm ET
-
-
-
-
-
-
-
BioMarin Pharma (BMRN) Misses Q4 EPS by 31c; offers guidance
-
-
-
-
-
-
-
BioMarin to acquire Amicus Therapeutics for $4.8 billion
-
-
-
-
-
-
-
BioMarin Pharma (BMRN) Tops Q2 EPS by 61c ; Offers Guidance
-
-
-
-
-
-
-
Cantor Fitzgerald Reiterates Overweight Rating on BioMarin Pharmaceutical Inc. (BMRN)
-
-
-
-
-
-
-
BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $91 at Stifel
-
-
-
-
-
-
-
BioMarin Pharmaceutical Inc. (BMRN) PT Lowered to $81 at Citi
-
1,198,946 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

